GoalVest Advisory’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,082
Closed -$13.5K – 548
2025
Q4
$13.5K Buy
+1,082
New +$11.7K ﹤0.01% 397
2025
Q2
– Sell
-12
Closed -$105 – 526
2025
Q1
$105 Buy
+12
New +$126 ﹤0.01% 496
2024
Q4
– Sell
-97
Closed -$1.13K – 437
2024
Q3
$1.13K Hold
97
– – ﹤0.01% 360
2024
Q2
$1.03K Hold
97
– – ﹤0.01% 302
2024
Q1
$1.16K Hold
97
– – ﹤0.01% 381
2023
Q4
$1.05K Buy
+97
New +$929 ﹤0.01% 349
2022
Q3
– Sell
-62
Closed -$1K – 314
2022
Q2
$1K Buy
+62
New +$680 ﹤0.01% 298

Other funds holding VTRS

GoalVest Advisory's VTRS Position: Q1 2026 in Review

GoalVest Advisory sold out of Viatris (VTRS) in Q1 2026, closing a stake of 1,082 shares — an estimated $13.5K sold.

GoalVest Advisory first reported a position in VTRS in Q2 2022 and held it in 7 quarters. The position peaked at $13.5K in Q4 2025. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • GoalVest Advisory reported no remaining Viatris position as of Q1 2026 after selling out during the quarter.
  • GoalVest Advisory sold 1,082 Viatris shares in Q1 2026, an estimated $13.5K.
  • GoalVest Advisory first reported a position in Viatris in Q2 2022 and held it in 7 quarters.
  • GoalVest Advisory's Viatris position peaked at $13.5K in Q4 2025.
  • 1,030 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on GoalVest Advisory's 13F filing for Q1 2026, filed 13 Apr 2026.